The healthcare sector naturally includes companies that provide healthcare services, manufacture and distribute healthcare equipment & supplies, and healthcare technology. It includes companies that research, develop, produce and market pharmaceuticals, biotechnology products, genetic tests, and medical devices.
The healthcare sector represents a key pillar of the IPO market, largely due to the amount of venture funding that pours into the development of new drug candidates, medical devices, and diagnostics and screening tools. Biotech investing is a high-risk endeavor, due to the fact that so many drug candidates fail to reach FDA approval. Investors often face one of two outcomes: either the drug is approved and the stock does well, or it is rejected and the stock plummets.
With that backdrop, prospective biotech investors examine the clinical results to date, the phase of ongoing clinical trials, the amount of private funding from reputable investors, and management's experience. Valuing a biotech or device company is more art than science, and investors often compare an IPO to the market cap of similar development-stage companies or an estimate of peak sales for a potential new drug. In addition to riskier early-stage companies, the healthcare sector also features defensive stocks that provide necessary services regardless of the economic environment, including profitable hospitals, pharmaceuticals, and healthcare research, manufacturing, and service providers.
Research upcoming health care IPOs this month with our IPO Calendar.
There are no scheduled Health Care IPOs. Check out the IPO Calendar to see upcoming IPOs from all sectors, or view the full pipeline of Health Care IPOs with a free trial of IPO Pro.
Research IPOs in the health care industry this year. Our Recently Priced IPOs page allows you to research health care stocks and various IPO metrics. Access advanced industry screening on IPO Pro.
Ticker | Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
---|---|---|---|---|---|---|---|
JUNS | Jupiter Neurosciences | JUNS | 12/02/24 | $11 | $5.54 |
n/a
n/a
|
38.5% |
SEPN | Septerna | SEPN | 10/24/24 | $288 | $26.06 |
$0.00
(0.0%)
|
44.8% |
CAMP | CAMP4 Therapeutics | CAMP | 10/10/24 | $75 | $5.91 |
$0.00
(0.0%)
|
-46.3% |
CBLL | CeriBell | CBLL | 10/10/24 | $180 | $28.94 |
$0.00
(0.0%)
|
70.2% |
UPB | Upstream Bio | UPB | 10/10/24 | $255 | $22.82 |
$0.00
(0.0%)
|
34.2% |
BIOA | BioAge Labs | BIOA | 09/25/24 | $198 | $18.09 |
$0.00
(0.0%)
|
0.5% |
GRDN | Guardian Pharmacy | GRDN | 09/25/24 | $112 | $24.77 |
$0.00
(0.0%)
|
76.9% |
KAPA | Kairos Pharma | KAPA | 09/16/24 | $6 | $1.50 |
$0.00
(0.0%)
|
-62.5% |
BCAX | Bicara Therapeutics | BCAX | 09/12/24 | $315 | $19.95 |
$0.00
(0.0%)
|
10.8% |
MBX | MBX Biosciences | MBX | 09/12/24 | $163 | $19.24 |
$0.00
(0.0%)
|
20.3% |
ZBIO | Zenas BioPharma | ZBIO | 09/12/24 | $225 | $9.84 |
$0.00
(0.0%)
|
-42.1% |
PTHL | Pheton | PTHL | 09/04/24 | $9 | $4.61 |
$0.00
(0.0%)
|
15.3% |
WOK | WORK Medical Technology | WOK | 08/22/24 | $8 | $5.89 |
$0.00
(0.0%)
|
47.3% |
ACTU | Actuate Therapeutics | ACTU | 08/12/24 | $22 | $8.77 |
$0.00
(0.0%)
|
9.6% |
OSTX | OS Therapies | OSTX | 07/31/24 | $6 | $1.96 |
$0.00
(0.0%)
|
-51.0% |
CON | Concentra | CON | 07/24/24 | $529 | $21.36 |
$0.00
(0.0%)
|
-9.1% |
ARTV | Artiva Biotherapeutics | ARTV | 07/18/24 | $167 | $12.72 |
$0.00
(0.0%)
|
6.0% |
ARDT | Ardent Health | ARDT | 07/17/24 | $192 | $16.83 |
$0.00
(0.0%)
|
5.2% |
ALMS | Alumis | ALMS | 06/27/24 | $210 | $7.99 |
$0.00
(0.0%)
|
-50.1% |
TEM | Tempus AI | TEM | 06/13/24 | $411 | $57.99 |
$0.00
(0.0%)
|
56.7% |
RAPP | Rapport Therapeutics | RAPP | 06/06/24 | $136 | $21.56 |
$0.00
(0.0%)
|
26.8% |
PACS | PACS Group | PACS | 04/10/24 | $450 | $15.18 |
$0.00
(0.0%)
|
-27.7% |
CTNM | Contineum Therapeutics | CTNM | 04/04/24 | $110 | $14.13 |
$0.00
(0.0%)
|
-11.7% |
BOLD | Boundless Bio | BOLD | 03/27/24 | $100 | $2.70 |
$0.00
(0.0%)
|
-83.1% |
AUNA | Auna | AUNA | 03/21/24 | $360 | $7.02 |
$0.00
(0.0%)
|
-41.5% |
MGX | Metagenomi | MGX | 02/08/24 | $94 | $1.86 |
$0.00
(0.0%)
|
-87.6% |
TELO | Telomir Pharmaceuticals | TELO | 02/08/24 | $7 | $5.16 |
$0.00
(0.0%)
|
-26.3% |
KYTX | Kyverna Therapeutics | KYTX | 02/07/24 | $319 | $4.95 |
$0.00
(0.0%)
|
-77.5% |
ANRO | Alto Neuroscience | ANRO | 02/01/24 | $129 | $4.16 |
$0.00
(0.0%)
|
-74.0% |
GUTS | Fractyl Health | GUTS | 02/01/24 | $110 | $2.18 |
$0.00
(0.0%)
|
-85.5% |
FBLG | FibroBiologics | FBLG | 01/31/24 | $ | $2.46 |
$0.00
(0.0%)
|
-69.3% |
AVBP | ArriVent BioPharma | AVBP | 01/25/24 | $175 | $29.25 |
$0.00
(0.0%)
|
62.5% |
BTSG | BrightSpring Health | BTSG | 01/25/24 | $693 | $18.71 |
$0.00
(0.0%)
|
43.9% |
CGON | CG Oncology | CGON | 01/24/24 | $380 | $35.91 |
$0.00
(0.0%)
|
89.0% |
These IPOs either had significant industry buzz, large capital raises,
or strong results.
These stocks are a sample of companies that you can
research further using our
IPO Pro
tools.